SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-16-112146
Filing Date
2016-04-18
Accepted
2016-04-18 16:58:33
Documents
5
Period of Report
2016-06-10
Effectiveness Date
2016-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A a16-2092_1def14a.htm DEF 14A 480070
2 GRAPHIC g20921bci001.gif GRAPHIC 5427
3 GRAPHIC g20921bci002.gif GRAPHIC 2494
4 GRAPHIC g20921cai001.gif GRAPHIC 104402
5 GRAPHIC g20921cai002.gif GRAPHIC 45355
  Complete submission text file 0001104659-16-112146.txt   698494
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36562 | Film No.: 161577338
SIC: 2834 Pharmaceutical Preparations